Vascular Solutions Braces For Duett Legal Battle v. St. Jude, Datascope
This article was originally published in The Gray Sheet
Executive Summary
Vascular Solutions' intellectual property portfolio for the Duett arterial puncture sealing device, approved June 26 by FDA, will face a stern test following a patent infringement claim filed by St. Jude July 10. A second complaint, initiated by Datascope, is expected imminently.
You may also be interested in...
St. Jude's $167 Mil. Angio-Seal Puncture Closure Buy Adds $50 Mil. In Sales
St. Jude's $167 mil. cash acquisition of marketing and manufacturing rights to Kensey Nash's Angio-Seal hemostatic puncture closure device from Tyco International would "more than double" sales into the cardiology cath lab by St. Jude's Daig division and add 60 to its sales and marketing staff, the firm states.
More Heartmate Troubles For Abbott. Latest Recall Includes 14 Deaths
Abbott initiated a recall in February of thousands of Heartmate devices due to a system obstruction that can result in serious health outcomes, including death. The FDA has now designated the recall as class I.
‘Unbalanced’ EU HTA Timelines Exacerbated By Rare Disease & Cancer Drugs
As it stands, drugmakers will have just 90 days to prepare their dossiers for EU-wide joint clinical assessments under the new Health Technology Assessment Regulation. Market access experts from EFPIA tell the Pink Sheet that this short deadline could delay patient access to complex medicines, such as innovative cancer drugs.